TAILIEUCHUNG - Ebook Pathophysiology of heart disease (5th edition): Part 2

(BQ) Part 2 book "Pathophysiology of heart disease" presents the following contents: Heart failure, the cardiomyopathies, mechanisms of cardiac arrhythmias, clinical aspects of cardiac arrhythmias, hypertension, diseases of the pericardium, diseases of the peripheral vasculature, congenital heart disease. | CHAPTER Heart Failure Neal Anjan Chatterjee Michael A. Fifer PHYSIOLOGY Determinants of Contractile Function in the Intact Heart Pressure-Volume Loops PATHOPHYSIOLOGY Heart Failure with Reduced EF Heart Failure with Preserved EF Right-Sided Heart Failure COMPENSATORY MECHANISMS Frank-Starling Mechanism Neurohormonal Alterations Ventricular Hypertrophy and Remodeling MYOCYTE LOSS AND CELLULAR DYSFuNcTION PRECIPITATING FACTORS CLINICAL MANIFESTATIONS Symptoms Physical Signs Diagnostic Studies F9 PROGNOSIS TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION Diuretics Vasodilators Inotropic Drugs p-Blockers Aldosterone Antagonist Therapy Additional Therapies TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION ACUTE HEART FAILURE Acute Pulmonary Edema The heart normally accepts blood at low filling pressures during diastole and then propels it forward at higher pressures in systole. Heart failure is present when the heart is unable to pump blood forward at a sufficient rate to meet the metabolic demands of the body forward failure or is able to do so only if the cardiac filling pressures are abnormally high backward failure or both. Although conditions outside the heart may cause this definition to be met through inadequate tissue perfusion . severe hemorrhage or increased metabolic demands . hyperthyroidism in this chapter only cardiac causes of heart failure are considered. Heart failure may be the final and most severe manifestation of nearly every form of cardiac disease including coronary atherosclerosis myocardial infarction valvular diseases hypertension congenital heart disease and the cardiomyopathies. More than 500 000 new cases are diagnosed each year in the United States where the current prevalence 216 Heart Failure is approximately 5 million. The number of patients with heart failure is increasing not only because the population is aging but also because of interventions that prolong survival after damaging cardiac insults such as .

• Y khoa - Dược
• Heart failure
• Pathophysiology of heart diseas
• The cardiomyopathies
• Mechanisms of cardiac arrhythmias
• Clinical aspects of cardiac arrhythmias
• Congenital heart disease
• Diseases of the pericardium
• Drug in heart failure
• Device selection in heart failure
• The pathophysiology of heart failure
• Traditional mechanical support
• Inotropic therapy for heart failure
• Lecture heart failure
• Classification of heart failure
• The cause of heart failure
• Symptoms of heart failure
• Heart failure Definition
• Percutaneous mechanical support
• Cardiac resynchronization therapy
• Atrial arrhythmias in heart failure
• Heart transplantation
• Patients with chronic heart failure
• Chronic heart failure
• Self care among patients
• Patient’s knowledge about heart failure
• Physical activity of the patients
• BMC Genomics
• RNA seq
• Gene expression
• Current heart failure
• Etiology specific gene
• BMC Geriatrics
• Heart failure stages
• Population attributable risk
• All cause mortality
• Heart failure management
• The neural pathways
• Barorefl ex activation therapy in heart failure
• Modulation of autonomic function
• Therapies in heart failure
• Listening to the heart
• Nervous system regulation
• Cerebral aging
• The autonomic nervous system
• NT proBNP
• Premature ventricular complexes
• Stable ischemic heart disease
• Chronic ischemic heart disease
• Heart muscle disease
• Heart rhythm disorders
• Peripheral vascular disease
• Heart disease in the young
• Heart disease in the elderly
• Cardiovascular drugs
• Evaluation and management
• Right sided heart failure
• Right heart failure
• Main points of RHF
• Cardiac embryogenesis
• BMC Veterinary Research
• Platelet proteomic
• Myxomatous mitral valve disease
• Congestive heart failure
• knowledge of medicine
• pharmacy management
• medication management
• vasodilators
• Extracorporeal membrane oxygenation
• Pathophysiology of heart failure
• Pediatric patients
• Respiratory failure
• Diastolic heart failure
• Cardiogenic shock
• Cardiovascular diseases
• Ischemic Heart Disease
• Stable ischemic heart disease
• Acute coronary syndromes
• Cardiac arrhythmias
• Ischemic stroke
• MCQs for cardiology knowledge based assessment
• Cardiology knowledge based assessment
• Ischaemic heart disease
• Valvular heart disease
• Adult congenital heart disease
• Cardiology clinical questions
• Cardiology clinical
• Congenital heart diseases
• Heart failure and hypertension
• Managing chronic heart failure patient
• Chronic kidney disease
• Modification of risk factors
• Quản lý bệnh nhân suy tim mãn tính
• Bệnh thận mãn tính
• Điều trị bệnh thận
• Study of clinical characteristic
• Risk factors
• Deep vein thrombosis
• Lower extremities
• Pulmonary emboli
• Practical cardiovascular medicine
• Non‐ST‐Segment elevation acute coronary syndrome
• ST‐segment elevation myocardial infarction
• Additional heart failure topics
• Valvular disorders
• Left ventricular filling pressure
• Diastolic dysfunction
• Echocardiography guidelines
• Doppler echocardiography
• Renal dysfunction
• Estimated glomerular filtration rate
• Left ventricular ejection fraction
• Serum BNP
• Heart failure with preserved ejection fraction
• Narrow QRS complex
• Speckle tracking echocardiography
• Dyssynchrony remains unclear
• QRS complex